Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v10-EN
Language French English
Date Updated 2020-03-04 2020-02-12
Drug Identification Number 02341689 02341689
Brand name GD-DICLOFENAC/MISOPROSTOL 50 GD-DICLOFENAC/MISOPROSTOL 50
Common or Proper name GD-DICLOFENAC/MISOPROSTOL 50 GD-DICLOFENAC/MISOPROSTOL 50
Company Name GENMED A DIVISION OF PFIZER CANADA ULC GENMED A DIVISION OF PFIZER CANADA ULC
Ingredients MISOPROSTOL DICLOFENAC SODIUM MISOPROSTOL DICLOFENAC SODIUM
Strength(s) 200MCG 50MG 200MCG 50MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 250's 250's
ATC code M01AB M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-22 2019-11-22
Estimated end date 2020-03-04 2020-03-04
Actual end date 2020-03-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Limited inventory available and on preventative allocation until approx March 4, 2020. Other presentation available: Arthrotec 50mg Limited inventory available and on preventative allocation until approx March 4, 2020. Other presentation available: Arthrotec 50mg
Health Canada comments